A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement
Completed · Phase 4
Conditions studied: Atrial Fibrillation, Cryoablation
In brief
This is a prospective trial investigating the effectiveness of a modified MRI preparatory pulse sequence to improve pulmonary vein isolation visualization.
Key facts
- Study ID
- NCT02875730
- Run by
- Aspire Foundation
- People needed
- 10
- Starts
- 2016-12-13
- Expected to finish
- 2018-04-27
- Last updated by the study team
- 2018-06-29
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men or non-pregnant women
- A diagnosis of symptomatic paroxysmal or recently persistent atrial fibrillation with a documented successful cardioversion within 4 months of the procedure
- Documented treatment failure or intolerance of at least 1 anti-arrhythmic medication used to control atrial fibrillation.
You may not qualify if…
- Contraindication to MRI, such as implanted incompatible metal prosthesis, or subject size exceeds bore or table limits
- Allergy to gadolinium-based contrast agent
- Previous atrial fibrillation ablation
- Renal dysfunction (estimated GFR <60 mL/min/1.73m2) within 6 months
- Unwilling to provide informed consent for this protocol
Where it is running
- Saint Luke's Health System — Kansas City, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.